Treatment of Early Onset Schizophrenia Spectrum Disorders (TEOSS)
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and efficacy of risperidone (Risperdal®), olanzapine
(Zyprexa®), and molindone (Moban®) for the treatment of children and adolescents with
schizophrenia or schizoaffective disorder.